Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing in pheochromocytoma: increasing importance for clinical decision making.

Annals of the New York Academy of Sciences - 1 Aug 2006

Bornstein Stefan R, Gimenez-Roqueplo Anne-Paule

Abstract excerpt

Hereditary pheochromocytomas and paragangliomas are caused by germline mutations in syndrome-associated genes. This includes multiple endocrine neoplasia Type 2 (MEN 2) caused by mutations in the RET proto-oncogene, von Hippel-Lindau (VHL) syndrome due to mutations of the VHL gene, neurofibromatosis Type I (NF1) caused by mutations of the NF1 gene, and pheochromocytoma/paraganglioma syndromes due to mutations in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to NF1 gene
Share to SDHD gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Pheochromocytoma

Share to Practice Patterns, Physicians'

Share to Proto-Oncogene Mas

Source

Identifiers

PMID: 17102076
DOI: 10.1196/annals.1353.010

Genes

VHL
NF1
RET
SDHB
SDHD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing in pheochromocytoma: increasing importance for clinical decision making.PMID 17102076Read ↗

Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.Semantic proximity Read ↗

Genetic testing for pheochromocytoma-associated syndromes.Semantic proximity Read ↗

Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paragangliomaSemantic proximity Read ↗

Pheochromocytoma: an update on genetics and management.Semantic proximity Read ↗

The genetics of phaeochromocytoma: using clinical features to guide genetic testing.Semantic proximity Read ↗

Genetic testing in pheochromocytoma or functional paraganglioma.Semantic proximity Read ↗

Pheochromocytoma: The Expanding Genetic Differential DiagnosisSemantic proximity Read ↗

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.Semantic proximity Read ↗

Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and ParagangliomaSemantic proximity Read ↗

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.Semantic proximity Read ↗

A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.